Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/12/2026

Systematic Neurological Examination in Infants – Evidence‑Based Recommendations

1. Core Assessment Tools

  • General Movements Assessment (Prechtl Qualitative) identifies motor dysfunction with 95‑98 % predictive accuracy for cerebral palsy in infants < 5 months corrected age. 1
  • Hammersmith Infant Neurological Examination (HINE)
    • Scores < 57 at 3 months predict cerebral palsy with 96 % accuracy. 1
    • When used alone, provides 90 % sensitivity for detecting neurological abnormalities. 1
  • Test of Infant Motor Performance (TIM​P) can be used as an alternative motor assessment when General Movements Assessment is unavailable. 1

2. Age‑Specific HINE Thresholds (Infants 5–24 months)

Age (months) HINE Score Interpretation Evidence
6, 9, 12 < 73 High risk for cerebral palsy [3][2]
Any < 40 Almost always indicates cerebral palsy [3]
Any 50‑73 Suggests unilateral CP; 95‑99 % will achieve independent walking [2]
Any < 50 Suggests bilateral CP [2]

3. Additional Motor Screening Instruments

  • Developmental Assessment of Young Children (DAYC) – 89 % predictive of cerebral palsy; can be completed via parent report. [3][2]
  • Alberta Infant Motor Scale (AIMS) – 86 % predictive of abnormal motor outcome. 3
  • Movement Assessment of Infants (MAI) – 73 % predictive of cerebral palsy. 3

4. Neuroimaging

  • Term‑age MRI detects abnormal neuroanatomy in motor‑related brain regions with 86‑89 % sensitivity when performed safely (often requiring sedation after 6 weeks). [1][2]3
  • MRI prognostic patterns:
    • Unilateral lesions / non‑cystic periventricular leukomalacia → likely ambulatory outcome. 1
    • Bilateral hemorrhages, cystic PVL, basal ganglia injury → likely non‑ambulatory outcome. 1

5. Red‑Flag Clinical Findings Requiring Immediate Standardized Assessment

  • Hand‑function asymmetry at any age. 2
  • Inability to bear weight through the plantar surface of the feet. 2

6. High‑Risk Populations for Systematic Screening

  • Preterm infants. [1][4]
  • Infants with neonatal encephalopathy. 2
  • Infants with congenital birth defects. 2
  • Infants admitted to a neonatal intensive care unit (NICU). 4

7. Essential Examination Components

Motor Function

  • Assessment of muscle tone (hypotonia, hypertonia, spasticity). 2
  • Evaluation of spontaneous movement quality and quantity. 2
  • Observation of posture, positioning, strength and age‑appropriate coordination. 2

Sensory Function

  • Tactile response, visual tracking/fixation, and auditory responsiveness. 2

Cranial Nerve & Primitive Reflexes

  • Facial symmetry and movement (CN VII). 2
  • Sucking, swallowing (CN IX, X, XII) and gag reflex (CN IX, X). 2
  • Palmar and plantar grasp reflexes. 2

8. Documentation Requirements

  • Record prenatal, perinatal, and postnatal risk factors and developmental milestone achievement. 2
  • Include any previous hospitalizations or complications. 4

9. Timing of Re‑Examination

  • Neonates (37 weeks gestation to 30 days old) – repeat assessment after 24 hours. 4
  • Infants > 30 days (up to 18 years) – repeat after 12 hours. 4
  • Defer assessment 24‑48 hours (or longer) after cardiopulmonary resuscitation or severe acute brain injury. 4

10. Medication Effects on Examination

  • Discontinue sedating anticonvulsants for an appropriate elimination‑half‑life period before the exam. 4
  • Verify therapeutic drug levels; avoid making a neurological diagnosis when supratherapeutic or high‑therapeutic sedative levels are present. 4
  • Low‑to‑mid therapeutic levels are unlikely to affect examination findings. 4

11. Practical Examination Strategies

  • Perform the exam when the infant is alert and calm. 1
  • Use toys and visual stimuli to assess tracking and attention. 2
  • Observe spontaneous movements before handling the infant. 2
  • Begin with least disturbing components (observation, cranial nerves) and finish with more stimulating tests. 2

12. Prognostic Prediction When Abnormalities Detected

  • HINE scores 40‑60 at 3‑6 months predict GMFCS levels I‑II (milder functional impairment). [3][2]
  • HINE scores < 40 predict GMFCS levels III‑V (more severe impairment). 2

13. Integrated Diagnostic Approach

  • Combining standardized neurological examination, motor assessments, detailed clinical history, and neuroimaging (when indicated) yields the most accurate evaluation of infant neurodevelopment. [1][5]2
  • A normal neuroimaging study does not exclude a neurological diagnosis. 1